CeraPedics Announces Addition To its Clinical Advisory Panel.

LAKEWOOD, Colo. -- Bharat Desai, M.D. Joins Colorado-based Company that Developed Revolutionary New Bone Graft Material

CeraPedics, a privately held company focused on the development of synthetic bone graft products incorporating its proprietary P-15(TM) technology, announced today that it has added Bharat M. Desai, M.D. to its Clinical Advisory Panel. Dr. Desai is currently in private practice at Panorama Orthopedics, PC in Golden, Colo. CeraPedics' Clinical Advisory Panel will play a key role in the development and commercialization of the P-15 technology for orthopaedic applications.

"We are delighted that Dr. Desai has agreed to join our Clinical Advisory Panel," said Andrew Tofe, Ph.D, President and CEO of CeraPedics. "His experience in dealing with orthopedic trauma, as well as his extensive knowledge of bone substitute products, will make his input invaluable as we develop the P-15 technology for trauma indications."

Dr. Desai is a Board Certified Orthopaedic Surgeon. He received his medical degree from Temple University School of Medicine in Philadelphia. He served a mixed surgical internship, as well as, an orthopaedic residency at Geisinger Medical Center in Danville, PA. In addition, he completed an ACE Trauma Fellowship at Harborview Medical Center in Seattle, WA. Dr. Desai is very active in the medical community as a member of the Colorado Orthopaedic Society, the American Medical Association and the American Academy of Orthopaedic Surgery, and has specialized in orthopedic trauma for the past 10 years with a special interest in the healing of traumatic injuries and osteobiologics.

Dr. Desai joins other distinguished members, Michael Janssen, D.O.; Courtney Brown, M.D.; and Vikas Patel, M.D., on the CeraPedics Clinical Advisory Panel. Dr. Janssen is Chairman of the Board of AO Spine International, as well as the Spine Education and Research Institute, one of the leading centers for the study of non-fusion technologies. Dr. Brown is the founding president of the Colorado Orthopaedic Society, former chairman of the American Academy of Orthopaedic Surgeons' Committee on Rehabilitation and was a consultant to the U.S. Olympic Ski Team for 25 years. Dr. Patel is an Assistant Professor of Orthopaedics, and Chief of Orthopaedic Spine Surgery at the University of Colorado and has conducted extensive research in spinal non-fusion technologies, alternative bone graft materials and minimally-invasive surgical techniques.

CeraPedics, L.L.C., founded in 2000 in Lakewood, Colorado, is a privately held company with proprietary technology developing a line of bone substitute products and implant coatings that employ the company's small peptide P-15 technology to facilitate bone formation in orthopaedic procedures. The Company's first product, P-15 Putty, is an orthopaedic bone graft material consisting of the synthetic P-15 peptide bound to anorganic bone mineral (ABM), suspended in an inert hydrogel carrier. CeraPedics is currently conducting a pivotal human clinical study evaluating P-15 Putty for use in the United States for cervical spine fusion.